Supplement | HBS Case Collection | September 2008 (Revised April 2009)

Kevin Sharer at Amgen: Sustaining the High-Growth Company (B)

by William W. George

Abstract

Kevin Sharer, CEO of Amgen, is assessing the challenges he has faced as a major product came under regulatory scrutiny.

Keywords: Governing Rules, Regulations, and Reforms; Leadership; Product Development; Biotechnology Industry;

Citation:

George, William W. "Kevin Sharer at Amgen: Sustaining the High-Growth Company (B)." Harvard Business School Supplement 409-037, September 2008. (Revised April 2009.)